Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ginwa Enterprise (Group) Inc. (600080.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
8.27-0.04 (-0.48%)
At close: 03:00PM CST
Advertisement

Ginwa Enterprise (Group) Inc.

No. 202, Keji 4th Road
High-tech Zone
Xi'an
China
86 29 8220 0221
https://www.ginwa.com.cn

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees607

Key Executives

NameTitlePayExercisedYear Born
Mr. Ming SunBoard Sec.N/AN/A1972
Ms. Yajuan JuFinancial DirectorN/AN/A1981
Mr. Boyue XingDeputy GM & DirectorN/AN/A1996
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells proprietary Chinese, biological, and chemical medicines in China. It offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. The company provides its products in the form of capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. is based in Xi'an, China.

Corporate Governance

Ginwa Enterprise (Group) Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement